RE:In at $1.3 Target $2This is a segment problem. It reminds me when Obama attacked coal and all the coal stocks tanked and never recovered. Hillary is after big Pharma and until the election the segment will suffer. Once they see she is powerless to manage companys of this size the market will ease back in and the companys with good growth, profits and balance sheets will shoot up. (MSL) should be one of them. Unike coal, people either need drugs or are addicted to their use and ultimatley these companies will continue to grow . I do think all Pharma companys will need to be more transparent and those who get ahead of that curve going forward will be the darlings of the industry, particularly for large fund managers.
My target is about $3.50 for March 2019. I can wait.
JMO